Target price | $222.48 |
Course | $197.20 |
Price potential | 12.82% |
Number of estimates | 57 |
57 Analysts have issued a price target Amazon.com 2025 . The average Amazon.com target price is $222.48. This is 12.82% higher than the current share price. The highest price target is $353.00 79.01% , the lowest is $180.00 8.72% . | |
A rating was issued by 65 analysts: 62 Analysts recommend Amazon.com to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Amazon.com share has an average upside potential 2025 of 12.82% . Most analysts recommend the Amazon.com share at Purchase. |
60 Analysts have issued a sales forecast Amazon.com 2024 . The average Amazon.com sales estimate is $639b . This is 8.14% higher than the turnover of the last 12 months(TTM). The highest sales forecast is $652b 10.34% , the lowest is $630b 6.66% .
This results in the following potential growth figures:
2023 | $575b | 11.83% |
---|---|---|
2024 | $639b | 11.14% |
2025 | $710b | 11.16% |
2026 | $786b | 10.71% |
2027 | $861b | 9.56% |
2028 | $925b | 7.36% |
36 Analysts have issued an Amazon.com EBITDA forecast 2024. The average Amazon.com EBITDA estimate is $137b . This is 40.50% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $147b 51.11% , the lowest is $116b 18.87% .
This results in the following potential growth figures and future EBITDA margins:
2023 | $86.3b | 55.65% |
---|---|---|
2024 | $137b | 58.58% |
2025 | $158b | 15.20% |
2026 | $179b | 13.66% |
2027 | $210b | 17.32% |
2028 | $242b | 14.93% |
2023 | 15.01% | 39.19% |
---|---|---|
2024 | 21.42% | 42.69% |
2025 | 22.20% | 3.64% |
2026 | 22.79% | 2.66% |
2027 | 24.40% | 7.06% |
2028 | 26.12% | 7.05% |
58 Amazon.com Analysts have issued a net profit forecast 2024. The average Amazon.com net profit estimate is $47.6b . This is 28.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $56.2b 51.69% , the lowest is $38.9b 5.06% .
This results in the following potential growth figures and future net margins:
2023 | $30.2b | 1,174.07% |
---|---|---|
2024 | $47.6b | 57.92% |
2025 | $60.8b | 27.68% |
2026 | $77.2b | 26.95% |
2027 | $90.8b | 17.61% |
2028 | $105b | 15.67% |
2023 | 5.25% | 1,060.46% |
---|---|---|
2024 | 7.46% | 42.13% |
2025 | 8.57% | 14.88% |
2026 | 9.82% | 14.59% |
2027 | 10.54% | 7.33% |
2028 | 11.36% | 7.78% |
58 Analysts have issued a Amazon.com forecast for earnings per share. The average Amazon.com <a href=/blog/eps>EPS is $4.58 . This is 28.65% higher than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is $5.40 51.69% , the lowest is $3.74 5.06% .
This results in the following potential growth figures and future valuations:
2023 | $2.90 | 1,174.07% |
---|---|---|
2024 | $4.58 | 57.93% |
2025 | $5.85 | 27.73% |
2026 | $7.42 | 26.84% |
2027 | $8.73 | 17.65% |
2028 | $10.10 | 15.69% |
Current | 55.38 | 82.73% |
---|---|---|
2024 | 43.06 | 22.25% |
2025 | 33.73 | 21.67% |
2026 | 26.57 | 21.23% |
2027 | 22.59 | 14.98% |
2028 | 19.53 | 13.55% |
Based on analysts' sales estimates for 2024, the Amazon.com share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of 3.32 and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of 3.21 .
This results in the following potential growth figures and future valuations:
Current | 3.59 | 31.99% |
---|---|---|
2024 | 3.32 | 7.54% |
2025 | 2.99 | 10.04% |
2026 | 2.70 | 9.67% |
2027 | 2.46 | 8.73% |
2028 | 2.29 | 6.86% |
Current | 3.47 | 36.33% |
---|---|---|
2024 | 3.21 | 7.52% |
2025 | 2.89 | 10.04% |
2026 | 2.61 | 9.67% |
2027 | 2.38 | 8.73% |
2028 | 2.22 | 6.86% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.